Year archive

SynAct Pharma — 2026 filings

All 24 regulatory filings released by SynAct Pharma (SYNACT) in 2026, sourced directly from the official regulator.

24 Filings

2026 Period

2026 filings (24)

Filing	Released	Lang
Kallelse till årsstämma i SynAct Pharma AB Regulatory Filings	2026-05-08	English
Notice of annual general meeting in SynAct Pharma AB Regulatory Filings	2026-05-07	English
SynAct Pharmas valberedning inför årsstämman 2026 Board/Management Information	2026-04-23	Swedish
SynAct Pharma’s Nomination Committee ahead of the 2026 Annual General Meeting Governance Information	2026-04-23	English
Annual Report (ESEF) 2025 Annual Report (ESEF) FY 2025	2026-04-15	Swedish
Major Shareholding Notification 2026 Major Shareholding Notification	2026-04-07	Swedish
Förändring av antalet aktier och röster i SynAct Pharma AB Share Issue/Capital Change	2026-03-31	Swedish
Change in number of shares and voting rights in Synact Pharma AB Share Issue/Capital Change	2026-03-31	English
Major Shareholding Notification 2026 Major Shareholding Notification	2026-03-27	Swedish
SynAct Pharma has carried out a directed issue of new shares of approximately 51.9 MSEK Capital/Financing Update	2026-03-02	English
SynAct Pharma har genomfört en riktad nyemission av aktier om cirka 51,9 MSEK Share Issue/Capital Change	2026-03-02	Swedish
SynAct Pharma offentliggör avsikt att genomföra en riktad nyemission om cirka 45 MSEK Capital/Financing Update	2026-03-02	Swedish
SynAct Pharma announces intention to carry out a directed issue of approximately 45 MSEK Capital/Financing Update	2026-03-02	English
SynAct Pharma appoints Ann Kristin Led as Chief Financial Officer Board/Management Information	2026-02-24	English
SynAct Pharma utser Ann Kristin Led till CFO Board/Management Information	2026-02-24	Swedish
Interim / Quarterly Report 2025 Interim / Quarterly Report Q4 2025	2026-02-18	Swedish
Interim / Quarterly Report 2025 Interim / Quarterly Report Q4 2025	2026-02-18	English
Återköp av aktier i Synact Pharma AB Transaction in Own Shares	2026-02-17	Swedish
Repurchase of shares in Synact Pharma AB Transaction in Own Shares	2026-02-17	English
Major Shareholding Notification 2026 Major Shareholding Notification	2026-01-28	Swedish
SynAct Pharmas utser Malin Wikstrand till tillförordnad CFO Board/Management Information	2026-01-19	Swedish
SynAct Pharma appoints Malin Wikstrand as interim CFO Board/Management Information	2026-01-19	English
Styrelsen för SynAct Pharma AB (publ) har beslutat om återköp av egna aktier Transaction in Own Shares	2026-01-09	Swedish
The Board of Directors of SynAct Pharma AB (publ) has resolved on the repurchase of own shares Transaction in Own Shares	2026-01-09	English